Pharmacotherapy for chronic obstructive pulmonary disease
10.5124/jkma.2019.62.5.277
- Author:
Yong Suk JO
1
;
Yong Bum PARK
Author Information
1. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. bfspark@kdh.or.kr
- Publication Type:Original Article
- Keywords:
Pulmonary disease, chronic obstructive;
Respiratory therapy
- MeSH:
Adrenal Cortex Hormones;
Bronchodilator Agents;
Cholinergic Antagonists;
Drug Therapy;
Exercise Tolerance;
Humans;
Pulmonary Disease, Chronic Obstructive;
Respiratory Therapy
- From:Journal of the Korean Medical Association
2019;62(5):277-282
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Appropriate pharmacologic therapy can reduce symptoms and risk and severity of exacerbations, as well as improve the health status and exercise tolerance of patients with chronic obstructive pulmonary disease. The most important medications for treating chronic obstructive pulmonary disease are inhaled bronchodilators including beta2-agonist and anticholinergics. Inhaled corticosteroids as anti-inflammatory drug should be considered in certain patients with caution considering risk and benefit. The choice within each class depends on the availability of medication and the patient's responses and preferences. Each treatment regimen needs to be individualized as the relationship between severity of symptoms, airflow limitation and severity of exacerbation can differ between patients.
